Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New NMDA/AMPA antagonists synthesized at Merck & Co.

Jan. 8, 1998

CoCensys and MGH expand license for migraine treatment technology

Jan. 8, 1998

Efficacy of muscle relaxant established in preclinical models

Jan. 8, 1998

Faulding establishes new U.S. division, regains rights to Kadian

Jan. 7, 1998

Bristol-Myers Squibb prepares melatonergic agents

Jan. 7, 1998

SKB reports prodrugs of 5-HT2C receptor antagonists

Jan. 7, 1998

New CNS growth factor identified by Boston Life Sciences collaborators

Jan. 7, 1998

Potential new application for lamotrigine in Lennox-Gastaut syndrome?

Jan. 7, 1998

Nootropic agent evaluated for the treatment of stroke

Jan. 5, 1998

Lubeluzole improves clinical outcome in stroke patients

Jan. 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2026.
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
Makary out at the FDA
BioWorld
U.S. President Donald Trump ended days of rumors and speculation when he confirmed May 12 that Marty Makary is resigning as FDA commissioner. Speaking with...